MedPath

Cork University Hospital

🇮🇪Ireland
Ownership
-
Established
1978-01-01
Employees
-
Market Cap
-
Website
http://cuh.hse.ie/

Viaskin Peanut Allergy Patch Shows Promise in Toddlers

• A clinical trial reveals that a skin patch, Viaskin, significantly increases peanut tolerance in toddlers with peanut allergies. • Approximately 67% of children aged one to three wearing the Viaskin patch for a year could safely ingest more peanut protein than before. • The study, involving 362 toddlers across eight countries, offers hope for a new treatment option where few exist for young children. • The Viaskin patch represents a potential alternative to strict avoidance, which can significantly impact the quality of life for children and families.
© Copyright 2025. All Rights Reserved by MedPath